These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33768297)

  • 1. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.
    Glocker C; Grohmann R; Engel R; Seifert J; Bleich S; Stübner S; Toto S; Schüle C
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1425-1435. PubMed ID: 33768297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.
    Glocker C; Grohmann R; Burkhardt G; Seifert J; Bleich S; Held T; Toto S; Stübner S; Schüle C
    J Neural Transm (Vienna); 2023 Feb; 130(2):153-163. PubMed ID: 36653686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe parkinsonism under treatment with antipsychotic drugs.
    Druschky K; Bleich S; Grohmann R; Engel RR; Toto S; Neyazi A; Däubl B; Stübner S
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):35-47. PubMed ID: 31444566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project.
    Druschky K; Bleich S; Grohmann R; Engel RR; Neyazi A; Stübner S; Toto S
    World J Biol Psychiatry; 2019 Nov; 20(9):732-741. PubMed ID: 30058414
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study.
    Druschky K; Toto S; Bleich S; Baumgärtner J; Engel RR; Grohmann R; Maier HB; Neyazi A; Rudolph YJ; Rüther E; Schwörer H; Seifert J; Stübner S; Degner D
    World J Biol Psychiatry; 2021 Jun; 22(5):373-386. PubMed ID: 32892689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project.
    Baumgärtner J; Grohmann R; Bleich S; Glocker C; Seifert J; Toto S; Rüther E; Engel RR; Stübner S
    World J Biol Psychiatry; 2022 Feb; 23(2):151-164. PubMed ID: 34096837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactorrhea due to psychotropic drugs.
    Kropp S; Ziegenbein M; Grohmann R; Engel RR; Degner D
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S84-8. PubMed ID: 15052519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.
    Seifert J; Maier HB; Führmann F; Bleich S; Stübner S; Sieberer M; Bernegger X; Greil W; Schüle C; Toto S; Grohmann R; Reinhard MA
    J Neural Transm (Vienna); 2022 Jul; 129(7):925-944. PubMed ID: 35524828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study.
    Grohmann R; Engel RR; Möller HJ; Rüther E; van der Velden JW; Stübner S
    Eur Arch Psychiatry Clin Neurosci; 2014 Mar; 264(2):131-41. PubMed ID: 23835526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
    Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
    Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.
    Druschky K; Bleich S; Grohmann R; Burda K; Frieling H; Hillemacher T; Neyazi A; Stübner S; Toto S
    Eur Psychiatry; 2018 Oct; 54():117-123. PubMed ID: 30193142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
    Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
    J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016.
    Bleich L; Grohmann R; Greil W; Dabbert D; Erfurth A; Toto S; Seifert J
    J Neural Transm (Vienna); 2024 Sep; 131(9):1117-1134. PubMed ID: 39136776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013.
    Friedrich ME; Winkler D; Konstantinidis A; Huf W; Engel R; Toto S; Grohmann R; Kasper S
    Int J Neuropsychopharmacol; 2020 Feb; 23(2):67-75. PubMed ID: 31504560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.
    Köster M; Grohmann R; Engel RR; Nitsche MA; Rüther E; Degner D
    Psychopharmacology (Berl); 2013 Nov; 230(2):191-201. PubMed ID: 24068157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries.
    Winkler D; Grohmann R; Friedrich ME; Toto S; Bleich S; Seifert J; Konstantinidis A; Shariat SF; Kasper S; Pjrek E
    J Psychiatr Res; 2021 Dec; 144():412-420. PubMed ID: 34741839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme.
    Letmaier M; Grohmann R; Kren C; Toto S; Bleich S; Engel R; Gary T; Papageorgiou K; Konstantinidis A; Holl AK; Painold A; Kasper S
    World J Biol Psychiatry; 2018 Apr; 19(3):175-186. PubMed ID: 28112047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017.
    Seifert J; Engel RR; Bernegger X; Führmann F; Bleich S; Stübner S; Sieberer M; Greil W; Toto S; Grohmann R
    J Affect Disord; 2021 Feb; 281():547-556. PubMed ID: 33401143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.